These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17017966)

  • 1. Central serotonin2C receptor: from physiology to pathology.
    Di Giovanni G; Di Matteo V; Pierucci M; Benigno A; Esposito E
    Curr Top Med Chem; 2006; 6(18):1909-25. PubMed ID: 17017966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies?
    Di Giovanni G; Di Matteo V; Pierucci M; Benigno A; Esposito E
    Curr Med Chem; 2006; 13(25):3069-81. PubMed ID: 17073648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
    Adams W; van den Buuse M
    Neuropharmacology; 2011 Sep; 61(3):458-67. PubMed ID: 21477601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.
    De Deurwaerdère P; Lagière M; Bosc M; Navailles S
    Exp Brain Res; 2013 Oct; 230(4):477-511. PubMed ID: 23615975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders.
    Di Giovanni G; De Deurwaerdère P
    Pharmacol Ther; 2016 Jan; 157():125-62. PubMed ID: 26617215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.
    Berg KA; Clarke WP; Cunningham KA; Spampinato U
    Neuropharmacology; 2008 Nov; 55(6):969-76. PubMed ID: 18602407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
    Alex KD; Pehek EA
    Pharmacol Ther; 2007 Feb; 113(2):296-320. PubMed ID: 17049611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dorsal raphe nucleus 5-HT(1A) and 5-HT(2) receptors in tonic immobility modulation in guinea pigs.
    Ferreira MD; Menescal-de-Oliveira L
    Brain Res; 2009 Aug; 1285():69-76. PubMed ID: 19538947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short history of the 5-HT
    Palacios JM; Pazos A; Hoyer D
    Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of serotonin(2C) receptors in the lateral habenular nucleus increases the expression of depression-related behaviors in the hemiparkinsonian rat.
    Han LN; Zhang L; Li LB; Sun YN; Wang Y; Chen L; Guo Y; Zhang YM; Zhang QJ; Liu J
    Neuropharmacology; 2015 Jun; 93():68-79. PubMed ID: 25661701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT2C receptor modulators: a patent survey.
    Lee J; Jung ME; Lee J
    Expert Opin Ther Pat; 2010 Nov; 20(11):1429-55. PubMed ID: 20849206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro.
    Varcoe TJ; Kennaway DJ
    Brain Res; 2008 May; 1209():19-28. PubMed ID: 18400210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei.
    Serrats J; Mengod G; Cortés R
    J Chem Neuroanat; 2005 Mar; 29(2):83-91. PubMed ID: 15652696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Potential PET Radiotracer for the 5-HT
    Kim J; Moon BS; Lee BC; Lee HY; Kim HJ; Choo H; Pae AN; Cho YS; Min SJ
    ACS Chem Neurosci; 2017 May; 8(5):996-1003. PubMed ID: 28194935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
    Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
    Howell LL; Cunningham KA
    Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and drug reward: focus on 5-HT2C receptors.
    Higgins GA; Fletcher PJ
    Eur J Pharmacol; 2003 Nov; 480(1-3):151-62. PubMed ID: 14623358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.